Skip to main content

Table 1 Clinical characteristics and lipid analyses of the study population.

From: The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion

Trait

Controls (n = 161)

Cases (n = 212)

p-value

Age

46.8 ± 19.57 (161)

53.2 ± 12.08 (211)

<0.001

Gender(%female)

49.1 (161)

41.5 (212)

< 0.09

TC

183.9 ± 36.66 (161)

293.9 ± 72.83 (212)

*

TG

100.0 ± 37.81 (161)

376.7 ± 347.98 (212)

*

VLDL-C

11.1 ± 7.77 (133)

69.0 ± 57.90 (212)

*

VLDL-TG

47.7 ± 30.08 (133)

275.8 ± 256.25 (212)

<0.001

LDL-C

122.1 ± 31.08 (133)

180.5 ± 55.96 (211)

*

LDL-TG

29.9 ± 12.15 (133)

75.2 ± 177.92 (211)

<0.001

HDL-C

52.9 ± 14.18 (158)

40.6 ± 12.48 (212)

<0.001

HDL-TG

15.5 ± 4.88 (158)

21.7 ± 9.68 (212)

<0.001

TG/HDL-C

1.97 ± 1.42 (158)

11.46 ± 17.59 (212)

0.211

BMI

25.3 ± 4.08 (93)

27.7 ± 4.54 (154)

<0.001

  1. With the exception of gender, means and standard deviations are reported. * Use of these variables as a case selection criterion precludes report of a statistic.
  2. TC, total cholesterol; TG, triglyceride; VLDL-C, very low density lipoprotein – cholesterol; LDL-C, low density lipoprotein-cholesterol; HDL, high density lipoprotein; BMI, body mass index.